Financings Of The Fortnight: Is Merck Joining Other Recent Entrants Into Corporate Venture?
This article was originally published in The Pink Sheet Daily
Plus news on recent financings by Acetylon, Tengion, Advanced BioHealing and SymBio Pharmaceuticals.
You may also be interested in...
Plus news on recent financings by InterMune, Orphazyme, Valeritas and Crescendo Bioscience.
Celgene will get exclusive use of Quanticel's single-cell genomic analysis to tweak its clinical pipeline, and it also has exclusive options to acquire the venture-backed start-up.